AEON Biopharma, Inc. (AEON) stock forecast · P/E 0.0, $8.6M cap
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
This AEON forecast page states what the cached financials imply — not a price target and not a guarantee. AEON Biopharma, Inc. outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for AEON yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for AEON, so this page does not invent a growth rate.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next AEON 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the AEON stock page.
Not investment advice.